Mostrar el registro sencillo del ítem

dc.contributor.authorCatala-Lopez, Ferran 
dc.contributor.authorRidao, Manuel
dc.contributor.authorHurtado, Isabel
dc.contributor.authorNúñez-Beltrán, Amparo
dc.contributor.authorGènova-Maleras, Ricard
dc.contributor.authorAlonso-Arroyo, Adolfo
dc.contributor.authorTobías, Aurelio
dc.contributor.authorAleixandre-Benavent, Rafael
dc.contributor.authorCatalá, Miguel A
dc.contributor.authorTabarés-Seisdedos, Rafael
dc.date.accessioned2019-06-20T10:58:38Z
dc.date.available2019-06-20T10:58:38Z
dc.date.issued2019-06-14
dc.identifier.citationSyst Rev. 2019;8(1):141.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7795
dc.description.abstractBACKGROUND: Autism spectrum disorder (ASD) is a complex developmental disorder characterised by impaired social interaction and communication, and restrictive and repetitive behaviour. Previous systematic reviews have traditionally assessed the prevalence of ASD on global or regional context, with very few meta-analyses at the country level. The objective of this study will be to systematically evaluate published and unpublished observational studies that present prevalence and comorbidity of ASD among children, adolescent and adult population in Spain. METHODS/DESIGN: We designed and registered a study protocol for a systematic review and meta-analysis of descriptive epidemiology data. Observational studies (cohort, cross-sectional) reporting the prevalence of ASD and conducted in a wide range of people (e.g. general population, outpatient and/or school settings) will be included. The primary outcome will be the prevalence of ASD. Secondary outcomes will be the prevalence of any physical or mental comorbidity in association with ASD. No limitations will be imposed on publication status, study conduct period, and language of dissemination. Comprehensive literature searches will be conducted in seven electronic databases (from January 1980 onwards), including PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO, IME-Spanish Medical Index and IBECS-Spanish Bibliographic Index of Health Sciences. Grey literature will be identified through searching dissertation databases, Google Scholar and conference abstracts. Two team members will independently screen all citations, full-text articles, and abstract data. Potential conflicts will be resolved through discussion. The study methodological quality (or bias) will be appraised using an appropriate tool. If feasible, we will conduct random effects meta-analysis of observational data. Prevalence estimates will be stratified according to gender, age and geographical location. Additional analyses will be conducted to explore the potential sources of heterogeneity (e.g. methodological quality, sample size, diagnostic criteria). DISCUSSION: This systematic review and meta-analysis of observational data will identify, evaluate and integrate the epidemiological knowledge underlying the prevalence of ASD in Spain. The results of this study will be of interest to multiple audiences including patients, their families, caregivers, healthcare professional, scientists and policy makers. Results will be published in a peer-reviewed journal. Implications for future epidemiological research will be discussed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018090372.es_ES
dc.description.sponsorshipFC-L and RT-S are funded by the CIBERSAM/Institute of Health Carlos III. MR and IH are partially funded by the Spanish Health Services Research on Chronic Patients Network (REDISSEC)/Institute of Health Carlos III.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectAutism spectrum disorderes_ES
dc.subjectComorbidityes_ES
dc.subjectEpidemiological studyes_ES
dc.subjectMeta-analysises_ES
dc.subjectPrevalencees_ES
dc.subjectSpaines_ES
dc.subjectSystematic reviewes_ES
dc.subject.meshAutism Spectrum Disorder es_ES
dc.subject.meshMeta-Analysis es_ES
dc.subject.meshPrevalence es_ES
dc.titlePrevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studieses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID31200773es_ES
dc.format.volume8es_ES
dc.format.number1es_ES
dc.format.page141es_ES
dc.identifier.doi10.1186/s13643-019-1061-1es_ES
dc.contributor.funderRETICS-Servicios de Salud Orientados a Enfermedades Crónicas (REDISSEC-ISCIII) (España) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.identifier.e-issn2046-4053es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13643-019-1061-1es_ES
dc.identifier.journalSystematic reviewses_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidad::Departamento de Planificación y Economía de la Saludes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional